Kura Oncology: Fourth Quarter Financial Results Overview

Kura Oncology Reports Fourth Quarter Financial Results

Kura Oncology Inc., headquartered in San Diego, announced on Thursday that it recorded a net loss of $81 million for the fourth quarter.

The company reported a quarterly loss of 92 cents per share.

These figures were below analyst expectations, as a consensus of six analysts polled by Zacks Investment Research had anticipated a loss of 72 cents per share.

During the same period, Kura Oncology generated $17.3 million in revenue, which also did not meet projections. Five analysts surveyed by Zacks had forecasted revenue of $29.8 million.

For the entire fiscal year, the company posted a total loss of $278.7 million, or $3.18 per share, with annual revenue reaching $67.5 million.